Oculis Holding Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 14.6%.

Top 22 shareholders own 43.4% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17.5%	LSP Advisory B.V.,	7,324,664	€107.5m	0%	84.94%
5.57%	Landsbréf Hf.	2,335,841	€34.3m	0%	65.53%
4.94%	BVCF Management Ltd	2,070,020	€30.4m	0%	67.4%
4.85%	Pivotal BioVenture Partners LLC	2,032,296	€29.8m	0%	11.4%
3.18%	Novartis Venture Funds	1,335,492	€19.6m	0%	100.0%
2.09%	Riad Sherif	878,486	€12.9m	0%	no data
1.96%	abrdn plc	820,553	€12.0m	-25.4%	0.01%
1.04%	Chen's Group International Limited	436,378	€6.4m	-15.5%	no data
0.9%	Novartis AG	378,029	€5.5m	0%	no data
0.59%	Páll Jóhannesson	249,224	€3.7m	0%	no data
0.23%	Anthony Rosenberg	96,670	€1.4m	0%	no data
0.23%	Lombard Odier Darier Hentsch & Cie Asset Management	95,750	€1.4m	0%	0.02%
0.16%	Sylvia Cheung	66,808	€980.1k	0%	no data
0.044%	Merrill Lynch & Co. Inc., Banking Investments	18,258	€267.9k	6.43%	no data
0.042%	UBS Asset Management AG	17,777	€260.8k	7.74%	no data
0.036%	Geode Capital Management, LLC	14,944	€219.3k	0%	no data
0.032%	Northern Trust Global Investments	13,565	€199.0k	0%	no data
0.028%	Christina Ackermann	11,718	€171.9k	0%	no data
0.022%	State Street Global Advisors, Inc.	9,098	€133.5k	0%	no data
0.00013%	Bank of America Corporation, Asset Management Arm	55	€800.0	0%	no data
0.00001%	DuPont Capital Management Corporation	4	€61.5	0%	no data
0%	JPMorgan Chase & Co, Brokerage and Securities Investments	1	€0	0%	no data